--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About RGEN20260918C185
Biotechnology Ⅲ
Repligen Corporation was established in May 1981. The company is a leading supplier of key products for the production of biological agents. The Company manufactures Protein A for major life science companies under long-term supply agreements and also sells products directly to end users for use in their production processes. The company also applies its expertise in biological product development to the research and development of SecreFlo. SecreFlo is a synthetic human hormone that the company is developing as a new imaging agent for the diagnosis of pancreatitis and potentially a variety of pancreatic diseases. The company currently has two early-stage rare CNS disease programs in progress for Friedreich's ataxia and spinal muscular atrophy, and has entered phase I clinical trials. In addition, the company has licensed some intellectual property to Bristol-Myers Squibb Company and receives royalties from the company's net sales of Orencia products sold in the United States.
